To hear about similar clinical trials, please enter your email below
Trial Title:
Acute Myocardial Infarction in Cancer Patients
NCT ID:
NCT06281054
Condition:
Acute Myocardial Infarction
Cancer
Conditions: Official terms:
Myocardial Infarction
Infarction
Conditions: Keywords:
Acute myocardial infarction
Cancer
Incidence
Prognosis
Study type:
Observational
Overall status:
Active, not recruiting
Study design:
Time perspective:
Retrospective
Intervention:
Intervention type:
Procedure
Intervention name:
Revascularization
Description:
Performing PCI or CABG
Arm group label:
Revascularized Group
Summary:
Using national health insurance service database, current study aim to evaluate the risk
and prognosis of acute myocardial infarction in cancer patients and to find the optimal
treatment strategy for acute myocardial infarction that can improve long-term prognosis.
Detailed description:
This study will be conducted using Korean National Health Insurance Service database.
Patients who were diagnosed with cancer from 2002 to 2021 will be included in the study.
Using the selected patients, current study will analyze the incidence and prognosis of
acute myocardial infarction in cancer patients and the prognosis according to the
treatment method for acute myocardial infarction will be compared. Primary outcome will
be all-cause death. Secondary outcomes will be myocardial infarction, revascularization,
hospitalization for heart failure, stroke, and clinically relevant bleeding.
Criteria for eligibility:
Study pop:
Patients who were diagnosed with cancer from 2002 to 2021 will be considered in the
study. Among these patients, those diagnosed with acute myocardial infarction after the
diagnosis with cancer will be included in the study.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Patients diagnosed with cancer between 2002 and 2021
- Patients who were diagnosed with acute myocardial infarction after cancer diagnosis
Exclusion Criteria:
- Patients who died during period of cancer diagnosis
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Chonnam National University Hospital, Chonnam National University Medical School
Address:
City:
Gwangju
Country:
Korea, Republic of
Start date:
January 1, 2002
Completion date:
December 31, 2024
Lead sponsor:
Agency:
Samsung Medical Center
Agency class:
Other
Collaborator:
Agency:
Chonnam National University
Agency class:
Other
Source:
Samsung Medical Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06281054
